Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin/Cholesterol vs Lovastatin for DSAP
NCT04359823Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of lovastatin and cholesterol cream in disseminated superficial actinic porokeratosis (DSAP) (2 arms), sponsored by Medical University of South Carolina. Primary endpoints: Disseminated Actinic Porokeratosis General Assessment Severity Index at 12 weeks, Presence of Cornoid Lamella on Dermoscopy at 12 weeks and 1 more. Started Aug 2020; status: completed.
02
Drugs
lovastatincholesterol cream
03
Conditions
disseminated superficial actinic porokeratosis (DSAP)
Beyond the preview
Go deeper on NCT04359823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04359823.